Danaher Corporation $DHR Shares Newly Acquired by Graves Light Lenhart Wealth Inc.

Graves Light Lenhart Wealth Inc. acquired a new stake in shares of Danaher Corporation (NYSE:DHR) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 9,421 shares of the conglomerate’s stock, valued at approximately $2,087,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of DHR. Veery Capital LLC boosted its stake in shares of Danaher by 3.1% during the 3rd quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after buying an additional 48 shares during the last quarter. Studio Investment Management LLC increased its stake in shares of Danaher by 3.3% in the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after buying an additional 51 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after buying an additional 53 shares during the last quarter. JDH Wealth Management LLC raised its holdings in Danaher by 4.5% in the first quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock valued at $240,000 after acquiring an additional 55 shares in the last quarter. Finally, OLD Second National Bank of Aurora raised its holdings in Danaher by 0.5% in the first quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate’s stock valued at $2,297,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

Danaher stock opened at $217.33 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a fifty day moving average price of $210.88 and a two-hundred day moving average price of $194.44. The company has a market cap of $152.78 billion, a PE ratio of 38.60, a P/E/G ratio of 2.72 and a beta of 0.76.

Danaher (NYSE:DHR) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the company earned $0.77 earnings per share. The firm’s revenue was up 5.5% compared to the same quarter last year. Research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio is 28.42%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Barclays raised their price objective on shares of Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a report on Wednesday. UBS Group started coverage on shares of Danaher in a research note on Wednesday, September 9th. They issued a “buy” rating and a $250.00 target price on the stock. Evercore reaffirmed an “outperform” rating and set a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. The Goldman Sachs Group lifted their price target on Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Finally, TD Cowen lowered their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $235.23.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.